Keyvan Karimi Galougahi
Overview
Explore the profile of Keyvan Karimi Galougahi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali Z, Galougahi K, Stone G
EuroIntervention
. 2025 Feb;
21(3):e145-e146.
PMID: 39901635
No abstract available.
2.
Shin D, Galougahi K, Singh M, Caron E, Cannata M, Ciftcikal Y, et al.
Prog Cardiovasc Dis
. 2025 Jan;
88:75-79.
PMID: 39761789
Coronary artery disease (CAD) is the leading cause of mortality among patients with chronic kidney disease (CKD), presenting unique challenges in diagnosis and management. Advanced CKD patients often present with...
3.
Petrossian G, Ozdemir D, Galougahi K, Scheiner J, Thomas S, Shlofmitz R, et al.
US Cardiol
. 2024 Nov;
16:e15.
PMID: 39600836
Intravascular imaging with optical coherence tomography (OCT) and intravascular ultrasound provides superior visualization of the culprit plaques for acute coronary syndromes (ACS) compared with coronary angiography. Combined with angiography, intravascular...
4.
Shin D, Galougahi K, Spratt J, Maehara A, Collet C, Barbato E, et al.
JACC Cardiovasc Interv
. 2024 May;
17(10):1187-1199.
PMID: 38811101
Calcified nodules (CNs) are among the most challenging lesions to treat in contemporary percutaneous coronary intervention. CNs may be divided into 2 subtypes, eruptive and noneruptive, which have distinct histopathological...
5.
Galougahi K, Shin D, Dakroub A, Sakai K, Singh M, Malik S, et al.
Curr Cardiol Rep
. 2024 May;
26(7):757-765.
PMID: 38809401
Purpose Of Review: To provide a summary of prevalence, pathogenesis, and treatment of coronary calcified nodules (CNs). Recent Findings: CNs are most frequently detected at the sites of hinge motion...
6.
Ali Z, Garcia J, Galougahi K, Horst J, Gallo A, Shin D, et al.
Circ Cardiovasc Interv
. 2024 Mar;
17(3):e013192.
PMID: 38502720
Background: The importance of complete revascularization after percutaneous coronary intervention (PCI) in patients with left main coronary artery disease is uncertain. We investigated the clinical impact of complete revascularization in...
7.
Hansen T, Galougahi K, Tang O, Tsang M, Scherrer-Crosbie M, Arystarkhova E, et al.
Am J Physiol Heart Circ Physiol
. 2023 Dec;
326(3):H623-H635.
PMID: 38133617
Pulmonary hypertension (PH) consists of a heterogenous group of diseases that culminate in increased pulmonary arterial pressure and right ventricular (RV) dysfunction. We sought to investigate the role of FXYD1,...
8.
Galougahi K, Dakroub A, Chau K, Mathew R, Mullasari A, Singh B, et al.
Catheter Cardiovasc Interv
. 2023 May;
102(1):46-55.
PMID: 37245076
Studies utilizing intravascular imaging have replicated the findings of histopathological studies, identifying the most common substrates for acute coronary syndromes (ACS) as plaque rupture, erosion, and calcified nodule, with spontaneous...
9.
Ali Z, Galougahi K, Thomas S, Abu-Much A, Chau K, Dakroub A, et al.
Interv Cardiol Clin
. 2023 Mar;
12(2):215-224.
PMID: 36922062
Optical coherence tomography (OCT) provides high-resolution imaging of coronary arteries and can be used to optimize percutaneous coronary intervention (PCI). Intracoronary OCT, however, has had limited adoption in clinical practice....
10.
Galougahi K, Zhang Y, Kienzle V, Liu C, Quek L, Patel S, et al.
Physiol Rep
. 2023 Jan;
11(1):e15549.
PMID: 36597221
Efficacy of therapies that target the downstream nitric oxide (NO) pathway in pulmonary arterial hypertension (PAH) depends on the bioavailability of NO. Reduced NO level in PAH is secondary to...